There is some exciting news on the horizon for multiple sclerosis patients. Scientists are testing a vaccine that seems to halt the progression of the disease.

Sue Carlson was diagnosed with multiple sclerosis 10 years ago.

She says, "It came on suddenly and I was deteriorating quickly."

Her eyesight was failing, she was falling down and was forced to cut her workload in half but she found hope in a clinical trial for a new vaccine called NeuroVax.

"I had been on NeuroVax for about three months and I realized things were starting to come back," she says.

In fact, Sue Carlson now says her symptoms have gone away.

Dr. Arthur Vandenbark, PhD, a neuroimmunologist says, "We've had a few examples where we've had very, very good responses and many other examples where we've been able to stabilize the disease so it doesn't progress any further."

Scientists discovered that multiple sclerosis patients lose the FOXP3 gene.

Neurovax restores FOXP3 levels by expanding healthy cells that in turn block the bad cells that have become active.

If NeuroVax proves successful after more trials some patients might eventually be able to combat multiple sclerosis with a simple shot in the arm.

Dr. Vandenbark says, "Probably give them maybe three at the beginning once a month and then follow every three to six months with a booster injection."

Early results suggest that Neurovax might be able to treat MS in both early and late stages.

More extensive trials of Neurovax are beginning soon.